Safety and efficacy of Budesonide administration after endoscopic ballon dilation for Crohn disease patients with intestinal stenosis
Not Applicable
- Conditions
- Crohn's disease
- Registration Number
- JPRN-UMIN000031839
- Lead Sponsor
- Osaka University Graduate School of Medicine Department of Gastroenterology and Hepatology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 17
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with more than 5 centimeters long stenosis Patients with internal or external fistula Patients with active infection, including abscess Patients with oral treatment of antithrombotic drugs or low platelet that counts less than 50000 per microlitter Patients with cancer Patients under 20 years old Patients with severy bad general condition Patients who are administered steroids within 4 weeks Patients who are judged inapropriate by doctors
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method safety within 12 weeks after EBD
- Secondary Outcome Measures
Name Time Method safety within 52 weeks after EBD rate of non-intestinal resection, non-reEBD and non-hospitalization rate of non-restenosis at 52 weeks after EBD